BBristol Read More BioNTech Gains 20% On $11.1 Billion Bristol Deal3 June 2025 BioNTech (NASDAQ:BNTX) surged 20% after Bristol Myers Squibb (NYSE:BMY) agreed to license its bispecific antibody BNT327targeting PD-L1 and…